The Vaccine Book - 1st Edition - ISBN: 9780121072582, 9780080542669

The Vaccine Book

1st Edition

0.0 star rating Write a review
Editors: Barry Bloom Barry R. Bloom Paul-Henri Lambert
Paperback ISBN: 9780121072582
eBook ISBN: 9780080542669
Imprint: Academic Press
Published Date: 25th November 2002
Page Count: 436
Sales tax will be calculated at check-out Price includes VAT/GST
Price includes VAT/GST

Institutional Subscription

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.


The Vaccine Book provides comprehensive information on the current and future world of vaccines. It reveals the scientific opportunities and potential impact of vaccines, including economic and ethical challenges, problems encountered when producing vaccines, how clinical vaccine trials are designed, and how to introduce vaccines into widespread use. Although vaccines are now available for many diseases, there are still challenges ahead for major diseases such as AIDS, tuberculosis, and malaria. The Vaccine Book is designed for students, researchers, public health officials, and all others interested in increasing their understanding of vaccines.

Key Features

@introbul:Topics unique to this book: @bul:* Ethics

  • Economics
  • Diseases that could be prevented
  • Clinical trial designs
  • Ideas about the future of vaccines
  • Challenges facing research scientists in the vaccine area
  • Burden of vaccine-preventable illness and the impact of vaccines
  • Scientific obstacles to be overcome by existing and new vaccines
  • Basic mechanisms of host immunity and pathogen interaction with host tissues
  • New approaches to future vaccines against challenging diseases
  • Real and perceived safety issues which dominate vaccine development and vaccination policies
  • Microbial pathogenesis as a basis for vaccine design
  • Planning vaccine trials
  • Introducing new vaccines into the healthcare system
  • Future challenges for vaccines and immunizations


Biomedical researchers, health policy makers, advanced students, working scientists, pediatricians, and other vaccine users

Table of Contents

Global Burden of Disease. Immunology. Trial Design for Vaccines. Ethics and Vaccines. Understanding Microbial Pathogenesis as a Basis for Vaccine Design. Disease States and Vaccines: Selected Cases. Economics of Vaccines: From Vaccine Candidate to Commercialized Product. Vaccine Safety: Real and Perceived Issues. Introduction to New Vaccines in the Healthcare System. Future Challenges for Vaccines and Immunizations.


No. of pages:
© Academic Press 2003
25th November 2002
Academic Press
Paperback ISBN:
eBook ISBN:

About the Editor

Barry Bloom

Affiliations and Expertise

Harvard School of Public Health, Boston, Massachusetts, U.S.A.

Barry R. Bloom

Barry R. Bloom

Dr. Bloom is Harvard University's Distinguished Service Professor of the Department of Immunology and Infectious Diseases and Former Dean of the Harvard School of Public Health. He received a bachelor’s degree and an honorary Sc.D. from Amherst College, and a Ph.D. from Rockefeller University. He is widely recognized for his work in the area of cell-mediated immunity, infectious diseases, particularly tuberculosis and leprosy, and global health. The discovery of lymphocyte-produced cytokines and the development of genetic systems in mycobacteria are among his scientific contributions. He has published over 300 papers and edited 4 books. He served as a consultant to the White House on International Health Policy, was elected President of the American Association of Immunologists, and served as President of the Federation of American Societies for Experimental Biology.

Dr. Bloom has been extensively involved with the World Health Organization (WHO) for more than 40 years. He was a member of the WHO Advisory Committee on Health Research (ACHR) and chaired the WHO Committees on Immunology of Leprosy (IMMLEP), Immunology of Tuberculosis (IMMTUB), the Scientific and Technical Advisory Committee of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (STAC) and chaired the WHO Global Malaria Programme. He was first chair of the Board of Trustees of the International Vaccine Institute, Seoul, Korea. He as served on the National Advisory Councils of the U.S. National Institute of Allergy and Infectious Diseases, NIH, and the Center for Infectious Diseases, of the US Centers for Disease Control and Prevention. He currently serves on the scientific advisory boards of the Wellcome Trust Centre for Human Genetics, K-RITH, and Human Heredity and Health in Africa (H3Africa). He has received numerous awards for his scientific work including the first Bristol-Myers Award in Infectious Diseases, the Robert Koch Gold Medal for lifetime achievement in research, and shared the Novartis Award in Immunology. He was elected to membership of the U.S. National Academy of Sciences, the National Academy of Medicine, the American Academy of Arts and Sciences and the American Philosophical Society.

Affiliations and Expertise

Harvard University Distinguished Service Professor and Joan and Jack Jacobson Professor of Public Health, Harvard School of Public Health, Boston, MA, USA

Paul-Henri Lambert

Paul-Henri Lambert

Paul-Henri Lambert, MD, is now associated with the Centre of Vaccinology in the Department of Pathology and Immunology at University of Geneva. He is particularly interested in vaccination strategies and evaluation of adverse effects. He is directing the International Advanced Course of Vaccinology (ADVAC) organized under the auspices of the Fondation Mérieux and University of Geneva. He is a member of the Governing Board of the Tuberculosis Vaccine Initiative (TBVI) and past-chairman of the Human Vaccine Committee of the International Association for Biologicals (IABS) and of the WHO GACVS (Global Advisory Committee on Vaccine Safety). Paul Henri Lambert is a native of Belgium where he was boarded in Internal Medicine (University of Liege). He joined Frank Dixon at Scripps Institute, La Jolla, California, for his training then moved to University of Geneva Medical School where he became professor in the Departments of Medicine and of Pathology. His research activities lead him to decipher immunological mechanisms involved in autoimmune and immune complex-mediated diseases, in the pathogenesis of malaria and in new strategies to optimize vaccine immunogenicity. In 1987, he was appointed as chief Microbiology and Immunology at the World Health Organization and in 1994, Chief, Vaccine Research and Development, WHO Global Program for Vaccines and Immunization. He was then deeply involved in co-ordination of research aiming at the development of vaccines against diseases of major importance in developing countries. Paul-Henri Lambert is author or co-author of 436 publications, member of several international scientific boards, foreign member of the Royal Academy of Medicine in Belgium and Fellow of the American Association for the Advancement of Science.

Affiliations and Expertise

Professor, Centre of Vaccinology, University of Geneva, Switzerland


"This comprehensive book, consisting of 10 chapters written by leading experts in almost all facets of the vaccine research and development enterprise, should be a standard reference work for anyone from student to senior professional interested in the current challenges in and prospects for the science of vaccines." (Richard T. Mahoney, Bulletin of the World Health Organization, September 2004) "...This comprehensive book, consisting of 10 chapters written by leading experts in almost all facets of the vaccine research and development enterprise, should be a standard reference work for anyone from student to senior professional interested in the current challenges in and propsects for the science of vaccines." -BULLETIN OF THE WORLD HEALTH ORGANIZATION (2004) "...provides a thorough review on a wide variety of topics regarding vaccines and immunization. ...recommended for academic health science libraries and corporate libraries interested in vaccine development. Individual researchers studying vaccines, students, and public health officials may also benefit from the information found in this book." -E-STREAMS (2003) "...a useful reference book. ...should appeal to a wide audience, including health economists and strategists, microbiologists and epidemiologists." -MICROBIOLOGY TODAY (2003)

Ratings and Reviews